Select Date
- >
Loading available days...
Available Slots:
Overview
Dr. Venkata V Sampath is a highly experienced Medical Oncologist based in Hyderabad, Telangana, with 9 years of dedicated practice in the field of oncology. He holds an impressive academic background, having earned his qualifications including DM in Medical Oncology, MD, and MBBS. Dr. Sampath exhibits a profound commitment to the well-being of his patients, applying his extensive knowledge to provide personalized and effective cancer care.
Fluent in English, Hindi, and Telugu, he is well-equipped to communicate with a diverse patient base, ensuring that all individuals have a clear understanding of their diagnosis and treatment plans. His approach is characterized by empathy and diligence, aiming to create a supportive environment for patients navigating the complexities of cancer treatment.
As part of the esteemed Apollo group, Dr. Sampath has access to advanced medical technologies and a multidisciplinary team of experts, enhancing the quality of care he provides. He is dedicated to staying updated with the latest advancements in oncology, which allows him to offer the best possible options to his patients. Dr. Sampath's patient-centric philosophy is reflected in his thorough consultations and follow-up care, where he emphasizes education and support throughout the treatment journey.
Patients seeking a compassionate and knowledgeable Medical Oncologist will find Dr. Venkata V Sampath to be an excellent choice, committed to delivering outstanding healthcare in the realm of oncology.
Experience
- Presently Working as Consultant Medical Oncology at Apollo Hospitals Jubileehills since last Assignment
- Assistant Professor, Department of Medical Oncology, SVIMS, From August 2014 to August 2015
- Consultant Oncologist at Yashoda Hospital, Secunderabad from Augus 2015
Memberships
- American Society of Medical Oncology(ASCO)
- European Society of Medical Oncology(ESMO)
- AROI
Awards
- Published research work an dcase reports in several reputed journals and presented at international conferences
PRESENTATIONS:
- Empowering patients to use tablet computer in calculating their own DAS scores; Results of a novel study. U Karjigi, et al. EULAR 2015, Rome, Italy.
- Refractory Multisystem Sarcoidosis responding to Infliximab. U Karjigi, A Paul BSR 2013, Birmingham, UK.
- Assessing the Cardiovascular risk burden in patients with RA: Role of Annual review clinic. V Patil, U Karjigi, et al EULAR 2012, Berlin, Germany.
- Acute Polymyositis associated with Haemophagocytic Lymphohistiocytosis U karjigi, M Plant Rheumatology meeting 2012, York, UK
- Multisystem Sarcoidosis involving pelvic bone responding to Infliximab U Karjigi, A Paul Rheumatology meeting 2012, York, UK
Research and Publication
Clinical Research Experience:
- Phase III, Inoperable Gastric Cancer, Sub Investigator, SVIMS/2011,
- Completed 20 Case Studies at time of M.D & D.M in NIMS & SVIMS
- A Prospective, multicenter, randomised, double blinded, 2-parallel groups, phase 3 study to compare as first line therapy efficacy and safety of masitinib in combination with gemcitabine, to gemcitabine in combination with placebo, followed as second line treatment by masitnib in combination with Folfiri 3 versus placebo in combination with Folfiri 3 in the treatment of patients with non resectable locally advanced or metastatic pancreatic cancer
- A prospective multicenter, randomized, double blind, placebo-controlled, 2-parallel groups, phase 3 study to compare the efficacy and safety of masatinib in combination with FOLFIRI (irinotecan, 5-fluorouracil and folinic acid) to placebo in combination with FOLFIRI in second line treatment of patients with metastatic colorectal cancer
- Clinico-pathological significance of HER 2 expression in gastric cancer: A retrospective study in Indian population- JCO 2013, ASCO Vol 31, No 15-Supplymentay May 20, 2013
- Letter to editor South Asian J Cancer 2013; 2: 192
- Study of quality of life in brain tumor patients treated with three-dimensional conformal radiotherapy- JCO, 2010 ASCO Annual Meeting Proceedings( Post- Meeting Edition) Vol 28. No 15_ suppl ( May 20 supplement), 201: 2091
Special Interests
- Precision Oncology, Targeted therapy, Immuno oncology, Solid and Haematological malignancies, Breast cancer, Lung cancer, Ovarian cancer, Colon cancer, Prostate cancer, Stomach Cncer
List of Treatments
- Bad Breath Halitosis Treatment
List of Conditions Treated
- Actinic keratosis
- Cholangiocarcinoma
- Hairy cell leukemia
- Ovarian cysts
- Acute Lymphoblastic Leukemia
- Renal Cell Carcinoma
- Langerhans Cell Histiocytosis
- malignant-melanoma
- Gastric Cancer
Frequently Asked Questions
Where does Dr. V Venkata Sampath practice?
Dr. V Venkata Sampath is a practicing physician at Apollo Hospitals Jubilee Hills. This hospital offers comprehensive healthcare services and advanced medical expertise.
Why do patients visit Dr. V Venkata Sampath?
Dr. V Venkata Sampath is frequently consulted for chemotherapy treatment of solid malignancies and hematological malignancies, as well as for genetic counseling. For further details, please refer to his professional profile.
What do patients say about Dr. V Venkata Sampath?
Dr. V Venkata Sampath has received positive feedback from 5 patients, with 3 patients sharing their experiences. Patient testimonials are available.
What are Dr. V Venkata Sampath's medical qualifications?
Dr. V Venkata Sampath holds an MBBS, MD in Radiotherapy, and a DM in Oncology.
What are Dr. V Venkata Sampath's specializations?
Dr. V Venkata Sampath specializes in Medical Oncology, Radiation Oncology, and Hematologic Oncology.
How many years of experience does Dr. V Venkata Sampath have?
Dr. V Venkata Sampath possesses 20 years of experience in the medical field. His extensive experience spans various medical settings and contributes to his expertise.
Who is Dr. V Venkata Sampath?
Dr. Vankamamidi Venkata Sampath is a Medical and Radiation Oncologist. He completed his MBBS at Kamineni Institute of Medical Sciences, MD (Radiotherapy) at Nizam's Institute of Medical Sciences (NIMS), and DM (Medical Oncology) at Sri Venkateswara Institute of Medical Sciences (SVIMS). His clinical research experience includes participation in Phase III trials (e.g., inoperable gastric cancer) and numerous case studies. He has expertise in a wide range of cancers, including hematological malignancies, lung cancer, breast cancer, and various gastrointestinal cancers. His research also covers areas such as cancer biology, biostatistics, and stem cell transplantation. Dr. Sampath's extensive experience encompasses oncology, radiotherapy, and medical oncology, making him a highly qualified specialist.
Who is an oncologist?
An oncologist is a medical doctor specializing in cancer diagnosis, treatment, and patient care across all tissue and organ types. They are cancer specialists providing comprehensive oncology services.
What are the different branches of oncology?
Oncology comprises several specialized branches: medical oncology (chemotherapy), surgical oncology (tumor removal surgery), radiation oncology (radiation therapy), gynecologic oncology (female cancers), pediatric oncology (childhood cancers), and hematology-oncology (blood cancers).
What's the difference between a clinical and medical oncologist?
Medical oncologists treat cancer with systemic therapies like chemotherapy, hormone therapy, and biological agents. Clinical oncologists combine chemotherapy with radiation therapy.
